The observational Post-Market Clinical Follow-up activity with the dialysis catheters P-DLS from Joline GmbH & Co.KG.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030687

Enrollment

115

Registered

2022-11-17

Start date

2022-11-22

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N17 N18

Interventions

Group 1: Data collection from patients without additional examinations who are treated with the CE-marked paediatric ST dialysis catheters of Joline GmbH according to the indication within the framewo

Eligibility

Sex/Gender

All

Age

No minimum to 14 Years

Inclusion criteria

Inclusion criteria: -Clinical indication for extracorporeal blood purification and therefore the need for temporary vascular access. -Decision of the physician to use the CE-marked dialysis catheter ST (P-DLS) according to the indications written in the instructions for use. -A signed informed consent form

Exclusion criteria

Exclusion criteria: Patients with contraindications according to the instructions for use. -occluded or thrombosed vessels -Known allergic disposition to the material of the dialysis catheter

Design outcomes

Primary

Measure	Time frame
The aim of the PMCF activity is to confirm the safety, performance and benefit of the CE-marked paediatric ST dialysis catheters when used in clinical routine within the indication according to the instructions for use.	—

Countries

Austria, Germany

Contacts

Public ContactNatasa Mitrovic

LS medcap GmbH

natasa.mitrovic@lsmedcap.com0747198499545

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026